Suchbegriffe: COINFECTION - DRUG THERAPY , . Treffer: 4
Koehler, P; Bassetti, M; Chakrabarti, A; Chen, SCA; Colombo, AL; Hoenigl, M; Klimko, N; Lass-Flörl, C; Oladele, RO; Vinh, DC; Zhu, LP; Böll, B; Brüggemann, R; Gangneux, JP; Perfect, JR; Patterson, TF; Persigehl, T; Meis, JF; Ostrosky-Zeichner, L; White, PL; Verweij, PE; Cornely, OA, ;European, Confederation, of, Medical, Mycology;International, Society, for, Human, Animal, Mycology;Asia, Fungal, Working, Group;INFOCUS, LATAM/ISHAM, Working, Group;ISHAM, Pan, Africa, Mycology, Working, Group;European, Society, for, Clinical, Microbiology;Infectious, Diseases, Fungal, Infection, Study, Group;ESCMID, Study, Group, for, Infections, in, Critically, Ill, Patients;Interregional, Association, of, Clinical, Microbiology, and, Antimicrobial, Chemotherapy;Medical, Mycology, Society, of, Nigeria;Medical, Mycology, Society, of, China, Medicine, Education, Association;Infectious, Diseases, Working, Party, of, the, German, Society, for, Haematology, and, Medical, Oncology;Association, of, Medical, Microbiology;Infectious, Disease, Canada
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Lancet Infect Dis. 2021; 21(6):e149-e162
Doi: 10.1016/S1473-3099(20)30847-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mutz, P; Metz, P; Lempp, FA; Bender, S; Qu, B; Schöneweis, K; Seitz, S; Tu, T; Restuccia, A; Frankish, J; Dächert, C; Schusser, B; Koschny, R; Polychronidis, G; Schemmer, P; Hoffmann, K; Baumert, TF; Binder, M; Urban, S; Bartenschlager, R
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
GASTROENTEROLOGY. 2018; 154(6): 1791-1804.
Doi: 10.1053/j.gastro.2018.01.044
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mandorfer, M; Payer, BA; Niederecker, A; Lang, G; Aichelburg, MC; Strassl, R; Boesecke, C; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Reiberger, T
Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.
AIDS Patient Care STDS. 2014; 28(5): 221-227.
Doi: 10.1089/apc.2013.0359
Web of Science
PubMed
FullText
FullText_MUG
Mandorfer, M; Neukam, K; Reiberger, T; Payer, BA; Rivero, A; Puoti, M; Boesecke, C; Baumgarten, A; Grzeszczuk, A; Zangerle, R; Meyer-Olson, D; Rockstroh, JK; Trauner, M; Pineda, JA; Peck-Radosavljevic, M
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.
AIDS. 2013; 27(17): 2707-2714.
Doi: 10.1097/01.aids.0000432460.44593.ef
Web of Science
PubMed
FullText
FullText_MUG